HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
New Brunswick, NJ, January 4, 2012 — The HealthCare Institute of New Jersey (HINJ) today released key findings of its 2011 economic impact survey, which indicates that the life sciences continue to play a leading role in driving New Jersey’s economy. For the eighth consecutive year, the study was conducted by Deloitte.
Industry Researchers Honored with Coveted Thomas Alva Edison Patent Award
New Brunswick, NJ, November 16, 2011 — Researchers from several HealthCare Institute of New Jersey (HINJ) member companies were recently recognized for their breakthrough research and awarded the prestigious Thomas Alva Edison Patent Award from the Research and Development Council of New Jersey.
HealthCare Institute of New Jersey Names Megan E. Fielder Government Affairs Associate
New Brunswick, NJ, October 24, 2011 — Megan E. Fielder of Bridgewater has joined the staff of the HealthCare Institute of New Jersey (HINJ) as its Government Affairs Associate.
CHI & HINJ to Co-Host Congressional Briefing on Alzheimer’s Disease Research and Therapeutic Advancements, Innovations and Treatments
LaJolla, CA and New Brunswick, NJ, July 7, 2011 — CHI–California Healthcare Institute and the HealthCare Institute of New Jersey (HINJ) will host a congressional briefing to facilitate a dialogue about Alzheimer’s Disease research on Thursday, July 14 in Washington, DC.
HealthCare Institute of New Jersey Announces Senior Staff Reorganization
New Brunswick, NJ, April 27, 2011 — The HealthCare Institute of New Jersey (HINJ) today announced a reorganization of its senior staff. Steve Issenman has been appointed Senior Vice President-Federal and External Affairs, and Haskell Berman has been appointed Senior Vice President-State Affairs. Both appointments are effective immediately.
HealthCare Institute of New Jersey Selects New Steering Committee Leadership
New Brunswick, NJ, April 5, 2011 — The HealthCare Institute of New Jersey (HINJ) today announced that Charles Grezlak, Ph.D., vice president of state government affairs and policy for Merck & Co., Inc. is the new chairman of HINJ’s steering committee.
New Jersey’s Life Sciences Community Responds to Japanese Disaster
Cash and Medical Product Pledges and Donations Total More Than $29 Million New Brunswick, NJ, March 30, 2011 — New Jersey′s life sciences community is actively engaged in relief efforts in Japan following the earthquake and tsunami earlier this month. In addition, many companies are matching donations from employees to relief organizations.
HINJ and Rep. Pallone Host Roundtable Discussion on the Innovation Economy: Improving Health While Creating Jobs
New Brunswick, NJ, February 4, 2011 — The HealthCare Institute of New Jersey (HINJ) and U.S. Rep. Frank Pallone today held a joint roundtable discussion on research and development investments and spurring medical innovation to improve global human health and create jobs in central New Jersey.
Dean J. Paranicas Named Next HINJ President and Chief Executive Officer
New Brunswick, NJ, January 25, 2011 — The HealthCare Institute of New Jersey (HINJ) has selected Dean J. Paranicas as the next president and chief executive officer of the state′s life sciences industry association.
Economy Impacts NJ Life Science Industry, New HINJ Report Shows
State Needs to Be More Competitive Against Other States, Nations to Keep and Expand Life Science Jobs Bridgewater, NJ, December 21, 2010 — New Jersey′s biopharmaceutical and medical technology sectors felt the brunt of the recession and the aftereffects of significant merger activity in 2009, according to the HealthCare Institute of New Jersey′s (HINJ) most […]